Receptor imaging in oncology by means of nuclear medicine: current status.
about
Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imagingIn vivo imaging of molecular targets and their function in endocrinology.Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?Targeting prostate cancer with radiolabelled bombesins.Assays for membrane tyrosine kinase receptors: methods for high-throughput screening and utility for diagnostics.Designing phase 0 cancer clinical trials.Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studiesThe role of clinical imaging in oncological drug development.Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial.Metastatic colorectal cancer: recent advances in its clinical management.Molecular imaging of ectopic metabotropic glutamate 1 receptor in melanoma with a positron emission tomography radioprobe (18) F-FITM.Methylene diphosphonate-conjugated adriamycin liposomes: preparation, characteristics, and targeted therapy for osteosarcomas in vitro and in vivo.Radiolabeled peptides: valuable tools for the detection and treatment of cancer99mTc-LHRH in tumor receptor imaging.Protein Adsorption Patterns and Analysis on IV Nanoemulsions-The Key Factor Determining the Organ Distribution.Synthesis and evaluation of Tc-99m and fluorescence-labeled elastin-derived peptide, VAPG for multimodal tumor imaging in murine tumor model.MEDICINAL RADIOPHARMACEUTICAL CHEMISTRY OF METAL RADIOPHARMACEUTICALS
P2860
Q27023605-B294EF58-3FD2-4A4B-98EF-1FFF9F39FC27Q33637199-57993E54-7620-4379-94AD-E2E569B262AEQ34068083-B45A77C6-4553-4446-8565-2060E01FA764Q34335207-381419F5-6D6A-4CEC-B38E-E1D711C588CDQ35214872-88606CE2-3A99-4B53-9EF2-48D2C7D9E4ECQ36192716-3EFE9CD2-41DA-4177-9A87-4224B5F333CBQ36732115-C718A53A-2F4A-4E3D-A8E8-556736F9B045Q37033947-F4CA47A2-FA43-4E8C-8723-5B679F50EFDFQ37187098-371FD5C8-777C-4818-8B82-F6BFD14B5E0DQ37400515-08B435DF-0086-44C2-90DB-7D1B7F04A5DFQ37642801-1F3829E7-EBFC-41A6-9536-90D8F098C228Q39014061-051FA3C3-E491-4BEB-8061-2E05B3D00ED6Q39406200-292C89E9-0E69-4069-BD86-E3A7D7FB8050Q39596344-D2DB5329-C148-491F-83B7-4BE5859ABF9CQ40979226-9405B850-203A-4909-A8F0-9CF21C65B93AQ42271492-B11849B3-1D0D-4891-9665-068090DE908AQ48201162-AF1A1367-4BE9-4548-9EEB-42710BBAD68CQ56619661-6DBC05F7-E336-4C68-B2F3-CBA4AA2A4A30
P2860
Receptor imaging in oncology by means of nuclear medicine: current status.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Receptor imaging in oncology by means of nuclear medicine: current status.
@ast
Receptor imaging in oncology by means of nuclear medicine: current status.
@en
type
label
Receptor imaging in oncology by means of nuclear medicine: current status.
@ast
Receptor imaging in oncology by means of nuclear medicine: current status.
@en
prefLabel
Receptor imaging in oncology by means of nuclear medicine: current status.
@ast
Receptor imaging in oncology by means of nuclear medicine: current status.
@en
P356
P1476
Receptor imaging in oncology by means of nuclear medicine: current status.
@en
P2093
Bieke Van Den Bossche
Christophe Van de Wiele
P304
P356
10.1200/JCO.2004.10.216
P407
P577
2004-09-01T00:00:00Z